Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2022
Taiwan prosecutors grant Yingwenda executive deferred prosecution over unauthorized medical-device production
Ruling
Taiwan prosecutors granted a one-year deferred prosecution to an Yingwenda Technology executive after he admitted to manufacturing COVID-19 sampling swabs without authorization. The report states that Yingwenda had obtained manufacturing and sales licenses by the time of the disposition, and that Yingye International was ordered to pay NT$80,000. The disposition concerns the unauthorized production of the sampling swabs; the report does not describe further allegations, outcomes, or the identities of the individuals involved.
Company response
Remediation — 英穩達科技公司
並積極補正取得製造藥商、販賣藥商執照
Source excerpt
並積極補正取得製造藥商、販賣藥商執照
前年未經核准製造醫療器材下，就在桃園大溪工廠生產新冠肺炎採檢棒
桃檢偵結後予以緩起訴1年，謝姓董座應向國庫支付2萬、英業達公司則要支付8萬元。